Re: Oncologic Outcomes and Survival in pT0 Tumors After Radical Cystectomy in Patients Without Neoadjuvant Chemotherapy: Results from a Large Multicentre Collaborative Study Editorial Comment

被引：0
|
作者：
Wood, David P.
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 28 条
  • [21] Re: Long-Term Analysis of Oncological Outcomes after Laparoscopic Radical Cystectomy in Europe: Results from a Multicentre Study by the European Association of Urology (EAU) Section of Uro-Technology
    Baseskioglu, Barbaros
    JOURNAL OF UROLOGICAL SURGERY, 2015, 2 (02): : 104 - 104
  • [22] NO-RESPONSE AT MPMRI AFTER NEOADJUVANT PEMBROLIZUMAB IS A PROXY OF ADVERSE PATHOLOGICAL AND ONCOLOGICAL OUTCOMES IN PATIENTS TREATED WITH RADICAL CYSTECTOMY: INTERIM RESULTS FROM THE PURE01 STUDY
    Bandini, Marco
    Zaffuto, Emanuele
    Scuderi, Simone
    Pederzoli, Filippo
    Marandino, Laura
    Raggi, Daniele
    Barletta, Francesco
    Gandaglia, Giorgio
    Fossati, Nicola
    Burgio, Giusy
    Moschini, Marco
    Zamboni, Stefania
    Afferi, Luca
    Comana, Sabrina
    Briganti, Alberto
    Montorsi, Francesco
    Colombo, Renzo
    Necchi, Andrea
    Gallina, Andrea
    JOURNAL OF UROLOGY, 2020, 203 : E839 - E839
  • [23] ADVANCED BLADDER-CANCER (STAGES PT3B, PT4A, PN1 AND PN2) - IMPROVED SURVIVAL AFTER RADICAL CYSTECTOMY AND 3 ADJUVANT CYCLES OF CHEMOTHERAPY - RESULTS OF CONTROLLED PROSPECTIVE-STUDY - COMMENT
    DROLLER, MJ
    JOURNAL OF UROLOGY, 1992, 148 (02): : 306 - 307
  • [24] Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Gu?rin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration
    Lonati, Chiara
    Baumeister, Philipp
    Afferi, Luca
    Mari, Andrea
    Minervini, Andrea
    Krajewski, Wojciech
    Azizi, Sosan
    Hendricksen, Kees
    Martini, Alberto
    Necchi, Andrea
    Montorsi, Francesco
    Briganti, Alberto
    Colombo, Renzo
    Tafuri, Alessandro
    Antonelli, Alessandro
    Cerruto, Maria Angela
    Roupret, Morgan
    Masson-Lecomte, Alexandra
    Laukhtina, Ekaterina
    D'Andrea, David
    Shariat, Shahrokh F.
    Soria, Francesco
    Marra, Giancarlo
    Gontero, Paolo
    Contieri, Roberto
    Hurle, Rodolfo
    Valiquette, Anne Sophie
    Mir, M. Carmen
    Zamboni, Stefania
    Simeone, Claudio
    Klatte, Tobias
    Teoh, Jeremy Yuen-Chun
    Yoshida, Soichiro
    Fujii, Yasuhisa
    Carando, Roberto
    Schulz, Gerald B.
    Mordasini, Livio
    Mattei, Agostino
    Moschini, Marco
    EUROPEAN UROLOGY FOCUS, 2022, 8 (05): : 1270 - 1277
  • [25] Dissecting outcomes of patients (pts) with <ypT2N0 disease after neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer (MIBC): Results from a large, international, multicenter collaboration.
    Ravi, Praful
    Pond, Gregory Russell
    Diamantopoulos, Leonidas Nikolaos
    Jain, Rohit K.
    Skelton, William Paul
    Gupta, Sumati
    Tward, Jonathan David
    Olson, Kathleen
    Singh, Parminder
    Grunewald, Camilla Marisa
    Niegisch, Guenter
    Lee, Jae-Lyun
    Gallina, Andrea
    Bandini, Marco
    Necchi, Andrea
    Mossanen, Matthew
    McGregor, Bradley Alexander
    Curran, Catherine
    Grivas, Petros
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Re: Dutasteride Treatment over 2 Years Delays Prostate-Specific Antigen Progression in Patients with Biochemical Failure After Radical Therapy for Prostate Cancer: Results from the Randomised, Placebo-Controlled Avodart After Radical Therapy for Prostate Cancer Study (ARTS) Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2013, 189 (05): : 1716 - 1716
  • [27] Re: Do Mixed Histological Features Affect Survival Benefit from Neoadjuvant Platinum-Based Combination Chemotherapy in Patients with Locally Advanced Bladder Cancer? A Secondary Analysis of Southwest Oncology Group-Directed Intergroup Study (S8710) Editorial Comment
    Wood, David P.
    JOURNAL OF UROLOGY, 2012, 188 (01): : 72 - 72
  • [28] Comment re: Sternberg CN, Skoneczna I, Kerst JM, et al. Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial. Lancet Oncol 2015;16:76-86
    Ohlmann, Carsten-Henning
    Stoeckle, Michael
    EUROPEAN UROLOGY, 2015, 68 (06) : 1104 - 1105
123